Streetbeat News

Earnings

WLY

John Wiley & Sons (NYSE:WLY) reported Q3 adjusted EPS of $0.59, surpassing the $0.45 estimate, with sales of $460.70M also beating the $408.10M estimate. However, both earnings and sales saw a decrease compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:33 pm

ALIM

Alimera Sciences (NASDAQ:ALIM) reported a significant improvement in Q4 earnings, with EPS at $(0.07), up from $(0.54) YoY. Sales reached $26.31M, surpassing the $24.34M estimate and marking an 87.51% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:32 pm

ML

MoneyLion (NYSE:ML) reported Q4 sales of $112.96M, surpassing the consensus estimate of $112.50M by 0.41% and marking an 18.98% increase from the previous year's $94.94M.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:31 pm

SSYS

Stratasys (NASDAQ:SSYS) reported Q4 adjusted EPS of $0.02, meeting analyst estimates, with a 71.43% decrease from last year's $0.07. Sales were $156.34M, beating estimates by 1.39% but showing a 1.83% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:30 pm

FCEL

FuelCell Energy (FCEL) reported Q1 2024 GAAP EPS of $(0.050), surpassing the $(0.080) estimate. However, its sales of $16.700M fell short of the $23.820M estimate, marking a 54.95% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:30 pm

GLD

SPY

U.S. markets closed higher, influenced by economic data and Federal Reserve Chair Jerome Powell's comments, hinting at a potential interest rate cut. Asian and European markets showed mixed results, with gold reaching a new high due to lower U.S. interest rate expectations. Economic indicators included U.S. job growth and trade surplus figures, alongside commodity and forex market movements.

Portfolio Pulse from Akanksha Bakshi

March 07, 2024 | 12:29 pm

BITF

Bitfarms (NASDAQ:BITF) reported a Q4 EPS loss of $(0.19), significantly missing the analyst consensus estimate of $(0.03) by 533.33%.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:28 pm

NVEI

Nuvei Corporation (NASDAQ:NVEI) reported Q4 earnings surpassing estimates with adjusted earnings of 47 cents per share and sales of $321.52 million. Total volume increased by 53%, while adjusted EBITDA margin decreased. The company forecasts Q1 revenue between $322 million and $330 million, and 2024 revenue between $1.34 billion and $1.38 billion. Following the report, Nuvei's shares dropped by 9.8%. Analysts from RBC Capital, Wells Fargo, and Canaccord Genuity adjusted their price targets on Nuvei.

Portfolio Pulse from Avi Kapoor

March 07, 2024 | 12:28 pm

RNAC

Cartesian Therapeutics reported a FY23 net loss of $219.7 million, or $1.66 per share, a significant downturn from the previous year's net income of $35.4 million, or $0.24 per share.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:23 pm

VITL

Vital Farms projects its FY24 revenue to be $552M, slightly above the estimated $550.6M.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:22 pm